Motac Neuroscience is a provider of world-class science and innovative technologies to develop new treatments for disorders of the central nervous system



Motac provides highly-specialised preclinical services for the pharmaceutical and biotechnology industries to support the discovery and development of therapeutics for neurological and psychiatric disorders. Motac has extensive expertise and world-class research capabilities in neurodegenerative conditions, particularly Parkinson’s disease, other movement disorders and cognitive disorders. We specialise in preclinical proof-of-concept and efficacy studies. Find out more about our company »